Wioletta Rozpedek-Kaminska (Wioletta Rozpędek-Kamińska)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 27

Top Topics

Endoplasmic Reticulum

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Wioletta Rozpedek-Kaminska, Grzegorz Galita, Natalia Siwecka, Zuzanna Granek, Julia Barczuk, Kamil Saramowicz, Ireneusz Majsterek
NCI 159456 PERK Inhibitor as a Targeted Therapy for Lung Cancer: An In Vitro Study. Biomedicines 12 (4) (2024)
Natalia Siwecka, Grzegorz Galita, Zuzanna Granek, Wojciech Wiese, Ireneusz Majsterek, Wioletta Rozpedek-Kaminska
IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells. International journal of molecular sciences 25 (14) (2024)
Natalia Siwecka, Grzegorz Galita, Zuzanna Granek, Wojciech Wiese, Ireneusz Majsterek, Wioletta Rozpedek-Kaminska
IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells. International journal of molecular sciences 25 (14) (2024)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Kamil Saramowicz, Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Dariusz Pytel, Ireneusz Majsterek
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes. International journal of molecular sciences 25 (2) (2024)
Natalia Siwecka, Grzegorz Galita, Zuzanna Granek, Wojciech Wiese, Ireneusz Majsterek, Wioletta Rozpedek-Kaminska
IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells. International journal of molecular sciences 25 (14) (2024)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Natalia Siwecka, Zuzanna Granek, Julia Barczuk, Kamil Saramowicz, Ireneusz Majsterek
NCI 159456 PERK Inhibitor as a Targeted Therapy for Lung Cancer: An In Vitro Study. Biomedicines 12 (4) (2024)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Kamil Saramowicz, Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Dariusz Pytel, Ireneusz Majsterek
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes. International journal of molecular sciences 25 (2) (2024)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Kamil Saramowicz, Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Dariusz Pytel, Ireneusz Majsterek
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes. International journal of molecular sciences 25 (2) (2024)
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek
GBA1 Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance. International journal of molecular sciences 24 (3) (2023)
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpedek-Kaminska, Ireneusz Majsterek
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease. International journal of molecular sciences 25 (1) (2023)
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpedek-Kaminska, Ireneusz Majsterek
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease. International journal of molecular sciences 25 (1) (2023)
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek
GBA1 Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance. International journal of molecular sciences 24 (3) (2023)
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek
GBA1 Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance. International journal of molecular sciences 24 (3) (2023)
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpedek-Kaminska, Ireneusz Majsterek
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease. International journal of molecular sciences 25 (1) (2023)
Wojciech Wiese, Julia Barczuk, Olga Racinska, Natalia Siwecka, Wioletta Rozpedek-Kaminska, Artur Slupianek, Radoslaw Sierpinski, Ireneusz Majsterek
PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities. Cancers 15 (21) (2023)
Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek
GBA1 Gene Mutations in α-Synucleinopathies-Molecular Mechanisms Underlying Pathology and Their Clinical Significance. International journal of molecular sciences 24 (3) (2023)
Justyna Kuś, Kamil Saramowicz, Maria Czerniawska, Wojciech Wiese, Natalia Siwecka, Wioletta Rozpedek-Kaminska, Aleksandra Kucharska-Lusina, Dominik Strzelecki, Ireneusz Majsterek
Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis. International journal of molecular sciences 24 (16) (2023)
Natalia Siwecka, Kamil Saramowicz, Grzegorz Galita, Wioletta Rozpedek-Kaminska, Ireneusz Majsterek
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy. Pharmaceutics 15 (8) (2023)
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, Aleksandra Kucharska-Lusina, Wioletta Rozpedek-Kaminska, Ireneusz Majsterek
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease. International journal of molecular sciences 25 (1) (2023)
Lukasz Banach, Lukasz Janczewski, Jakub Kajdanek, Katarzyna Miłowska, Joanna Kolodziejczyk-Czepas, Grzegorz Galita, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek, Beata Kolesinska
Synthesis and Hemostatic Activity of New Amide Derivatives. Molecules (Basel, Switzerland) 27 (7) (2022)
Marta Kunert, Wioletta Rozpedek-Kaminska, Grzegorz Galita, Salvatore Sauro, Rim Bourgi, Louis Hardan, Ireneusz Majsterek, Monika Lukomska-Szymańska
The Cytotoxicity and Genotoxicity of Bioactive Dental Materials. Cells 11 (20) (2022)
Wojciech Wiese, Natalia Siwecka, Adam Wawrzynkiewicz, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek
IRE1α Inhibitors as a Promising Therapeutic Strategy in Blood Malignancies. Cancers 14 (10) (2022)
Julia Barczuk, Natalia Siwecka, Weronika Lusa, Wioletta Rozpedek-Kaminska, Ewa Kucharska, Ireneusz Majsterek
Targeting NLRP3-Mediated Neuroinflammation in Alzheimer's Disease Treatment. International journal of molecular sciences 23 (16) (2022)
Natalia Siwecka, Wioletta Rozpedek-Kaminska, Adam Wawrzynkiewicz, Dariusz Pytel, J Alan Diehl, Ireneusz Majsterek
The Structure, Activation and Signaling of IRE1 and Its Role in Determining Cell Fate. Biomedicines 9 (2) (2021)
Adam Wawrzynkiewicz, Wioletta Rozpedek-Kaminska, Grzegorz Galita, Monika Lukomska-Szymańska, Barbara Lapinska, Jerzy Sokolowski, Ireneusz Majsterek
The Toxicity of Universal Dental Adhesives: An In Vitro Study. Polymers 13 (16) (2021)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Natalia Siwecka, Steven L Carroll, John Alan Diehl, Ewa Kucharska, Dariusz Pytel, Ireneusz Majsterek
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment. International journal of molecular sciences 22 (9) (2021)
Wioletta Rozpedek-Kaminska, Radosław Wojtczak, Jacek P Szaflik, Jerzy Szaflik, Ireneusz Majsterek
The Genetic and Endoplasmic Reticulum-Mediated Molecular Mechanisms of Primary Open-Angle Glaucoma. International journal of molecular sciences 21 (11) (2020)